Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...

It took years of effort, but one new bill that passed the senate on Thursday will head to Governor Kelly Armstrong’s desk.

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...